Y. Christinat, Liza Ho, S. Clément, C. Genestie, J. Sehouli, Antonio González Martín, U. Denison, K. Fujiwara, I. Vergote, G. Tognon, S. Hietanen, E. Pujade-Lauraine, I. Ray-Coquard, T. McKee
{"title":"2022-RA-567-ESGO The Geneva HRD test: clinical validation on 469 samples from the PAOLA-1 trial","authors":"Y. Christinat, Liza Ho, S. Clément, C. Genestie, J. Sehouli, Antonio González Martín, U. Denison, K. Fujiwara, I. Vergote, G. Tognon, S. Hietanen, E. Pujade-Lauraine, I. Ray-Coquard, T. McKee","doi":"10.1136/ijgc-2022-esgo.514","DOIUrl":null,"url":null,"abstract":"2022-RA-567-ESGO Figure 1 Abstracts A238 Int J Gynecol Cancer 2022;32(Suppl 2):A1–A504 on D ecem er 4, 2022 by gest. P rocted by coright. http/ijgc.bm jcom / nt J G ynecol C acer: frst pulished as 10.11ijgc-2022-E S G O .14 on 20 O cber 222. D ow nladed fom Conclusion The proposed test is a viable alternative to the Myriad myChoice HRD test and can easily be implemented in a clinical laboratory for routine practice. The performance of the tests is similar in terms of hazard ratio but the lower failure rate of the Geneva HRD test allows a 10% increase in the number of patients receiving a conclusive laboratory result. 2022-VA-572-ESGO HUDSON POSTERIOR EXENTERATION, WITH THE USE OF ICG FLUORESCENCE TO ASSESS RECTAL ANASTOMOSIS AND URETERAL INTEGRITY Dong Bach Nguyen, Beatriz Navarro Santana, Guillaume Babin, Sara Forte, Mathilde Mairé, Frédéric Guyon. Gynécologie Oncologie, Institut Bergonié, Bordeaux, France 10.1136/ijgc-2022-ESGO.515 Introduction/Background The surgical approach to hysterectomy for ovarian cancer has remained largely unchanged since Hudson described the en-bloc resection of fixed ovarian tumors using a retrograde technique in 1968. When a colorectal resection is required for optimal debulking, anastomotic leak remains a significant concern. While the traditional techniques used to evaluate for anastomotic perfusion lack accuracy, data from a recent systematic review and meta-analysis favours the use of ICG intra-op to reduce the incidence of anastomotic leak and associated need for reintervention. Methodology With the use of surgical footage, this video aims to present the surgical steps to a Hudson procedure with colorectal resection, ending with the use of ICG fluorescence to assess the perfusion of the colorectal anastomosis and ureters. Results The surgical approach can be summarized in the following ten steps: (1) retroperitoneal dissection of the vascular pedicles and ureters, and transection of the IP ligament; (2) dissection of the paravesical and pararectal spaces; (3) lateral and pre-vesical peritonectomy; (4) ureterolysis and transection of the uterine vessels; (5) transection of the vesciouterine and uterosacral ligaments; (6) colpotomy; (7) mesorectal dissection and distal rectal transection; (8) proximal rectosigmoid transection; (9) vaginal vault closure and colorectal anastomosis; (10) assessment of colorectal anastomosis and ureteral vascularization by ICG fluorescence. Conclusion This video presented 10 reproducible steps to perform a Hudson procedure with colorectal resection for ovarian cancer. The use of ICG as an adjunct to assess the vascularization of the colorectal anastomosis appears to reduce the risk of anastomotic leak in colorectal surgery, and may be of interest in gynecologic-oncologic surgery. 2022-RA-576-ESGO EXPRESSION VIII – FIRST STUDY OF INDIVIDUAL PERCEPTION AND LEVEL OF INFORMATION OF PATIENTS WITH LOW GRADE OVARIAN CANCER AND BORDERLINE TUMOR OF THE OVARY IN 321 PATIENTS Laura Naomi Beckmann, Sara Alavi, Maren Keller, Clemens Liebrich, Karol Kubiak, Pauline Wimberger, Vera Czolk, Anette Ligl-Löhner, Hans-Martin Enzinger, Aline Burdack, Dorothea Fischer, Jürgen Terhaag, Cornelia Müller, Volker Hanf, Mateja Condic, Georg Kunz, Tilmann Lantzsch, Ute Schilling, Gülten Oskay-Özcelik, Jalid Sehouli. Department of Gynecology with Center for Oncological Surgery, European Compe-tence Center for Ovarian Cancer, Charité – Campus Virchow-Klinikum, University Medicine of Berlin, Berlin, Germany; North-Eastern German Society of Gynecological Oncology (NOGGO), Berlin, Germany; Gynäkologisches Krebszentrum, Klinikum Wolfsburg, Wolfsburg, Germany; St. Franziskus-Hospital GmbH, Münster, Germany; Department of Gynecology and Obstetrics, TU Dresden Medizinische Fakultat Carl Gustav Carus, Dresden, Germany; Diako Mannheim, Mannheim, Germany; Diakonissen-Stiftung-Krankenhaus Speyer, Speyer, Germany; Sozialstiftung Bamberg, Bamberg, Germany; Sana Klinikum Lichtenberg, Berlin, Germany; Klinikum Ernst von Bergmann gemeinnützige GmbH, Potsdam, Germany; Rottal-Inn Kliniken KU Eggenfelden, Eggenfelden, Germany; Universitätklinikum Brandenburg an der Havel, Brandenburg an der Havel, Germany; Klinikum Fürth, Fürth, Germany; Universitätsklinikum Bonn, Bonn, Germany; St.Johannes-Hospital Dortmund, Dortmund, Germany; Krankenhaus St. Elisabeth und St. Barbara Halle (Saale) GmbH, Halle (Saale), Germany; Park-Klinik Weißensee, Berlin,","PeriodicalId":89343,"journal":{"name":"Clinical ovarian cancer and other gynecologic malignancies","volume":"49 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical ovarian cancer and other gynecologic malignancies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2022-esgo.514","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
Abstract
2022-RA-567-ESGO Figure 1 Abstracts A238 Int J Gynecol Cancer 2022;32(Suppl 2):A1–A504 on D ecem er 4, 2022 by gest. P rocted by coright. http/ijgc.bm jcom / nt J G ynecol C acer: frst pulished as 10.11ijgc-2022-E S G O .14 on 20 O cber 222. D ow nladed fom Conclusion The proposed test is a viable alternative to the Myriad myChoice HRD test and can easily be implemented in a clinical laboratory for routine practice. The performance of the tests is similar in terms of hazard ratio but the lower failure rate of the Geneva HRD test allows a 10% increase in the number of patients receiving a conclusive laboratory result. 2022-VA-572-ESGO HUDSON POSTERIOR EXENTERATION, WITH THE USE OF ICG FLUORESCENCE TO ASSESS RECTAL ANASTOMOSIS AND URETERAL INTEGRITY Dong Bach Nguyen, Beatriz Navarro Santana, Guillaume Babin, Sara Forte, Mathilde Mairé, Frédéric Guyon. Gynécologie Oncologie, Institut Bergonié, Bordeaux, France 10.1136/ijgc-2022-ESGO.515 Introduction/Background The surgical approach to hysterectomy for ovarian cancer has remained largely unchanged since Hudson described the en-bloc resection of fixed ovarian tumors using a retrograde technique in 1968. When a colorectal resection is required for optimal debulking, anastomotic leak remains a significant concern. While the traditional techniques used to evaluate for anastomotic perfusion lack accuracy, data from a recent systematic review and meta-analysis favours the use of ICG intra-op to reduce the incidence of anastomotic leak and associated need for reintervention. Methodology With the use of surgical footage, this video aims to present the surgical steps to a Hudson procedure with colorectal resection, ending with the use of ICG fluorescence to assess the perfusion of the colorectal anastomosis and ureters. Results The surgical approach can be summarized in the following ten steps: (1) retroperitoneal dissection of the vascular pedicles and ureters, and transection of the IP ligament; (2) dissection of the paravesical and pararectal spaces; (3) lateral and pre-vesical peritonectomy; (4) ureterolysis and transection of the uterine vessels; (5) transection of the vesciouterine and uterosacral ligaments; (6) colpotomy; (7) mesorectal dissection and distal rectal transection; (8) proximal rectosigmoid transection; (9) vaginal vault closure and colorectal anastomosis; (10) assessment of colorectal anastomosis and ureteral vascularization by ICG fluorescence. Conclusion This video presented 10 reproducible steps to perform a Hudson procedure with colorectal resection for ovarian cancer. The use of ICG as an adjunct to assess the vascularization of the colorectal anastomosis appears to reduce the risk of anastomotic leak in colorectal surgery, and may be of interest in gynecologic-oncologic surgery. 2022-RA-576-ESGO EXPRESSION VIII – FIRST STUDY OF INDIVIDUAL PERCEPTION AND LEVEL OF INFORMATION OF PATIENTS WITH LOW GRADE OVARIAN CANCER AND BORDERLINE TUMOR OF THE OVARY IN 321 PATIENTS Laura Naomi Beckmann, Sara Alavi, Maren Keller, Clemens Liebrich, Karol Kubiak, Pauline Wimberger, Vera Czolk, Anette Ligl-Löhner, Hans-Martin Enzinger, Aline Burdack, Dorothea Fischer, Jürgen Terhaag, Cornelia Müller, Volker Hanf, Mateja Condic, Georg Kunz, Tilmann Lantzsch, Ute Schilling, Gülten Oskay-Özcelik, Jalid Sehouli. Department of Gynecology with Center for Oncological Surgery, European Compe-tence Center for Ovarian Cancer, Charité – Campus Virchow-Klinikum, University Medicine of Berlin, Berlin, Germany; North-Eastern German Society of Gynecological Oncology (NOGGO), Berlin, Germany; Gynäkologisches Krebszentrum, Klinikum Wolfsburg, Wolfsburg, Germany; St. Franziskus-Hospital GmbH, Münster, Germany; Department of Gynecology and Obstetrics, TU Dresden Medizinische Fakultat Carl Gustav Carus, Dresden, Germany; Diako Mannheim, Mannheim, Germany; Diakonissen-Stiftung-Krankenhaus Speyer, Speyer, Germany; Sozialstiftung Bamberg, Bamberg, Germany; Sana Klinikum Lichtenberg, Berlin, Germany; Klinikum Ernst von Bergmann gemeinnützige GmbH, Potsdam, Germany; Rottal-Inn Kliniken KU Eggenfelden, Eggenfelden, Germany; Universitätklinikum Brandenburg an der Havel, Brandenburg an der Havel, Germany; Klinikum Fürth, Fürth, Germany; Universitätsklinikum Bonn, Bonn, Germany; St.Johannes-Hospital Dortmund, Dortmund, Germany; Krankenhaus St. Elisabeth und St. Barbara Halle (Saale) GmbH, Halle (Saale), Germany; Park-Klinik Weißensee, Berlin,
[摘要]A238《国际妇科癌症杂志》(intj Gynecol Cancer) 2022;32(增刊2):A1-A504 on D]于2022年4月4日公布。P由赖特保护。http / ijgc。jj.com / nt jgynecol C acer:首次发表于2002年12月20日,论文号10.11ijgc-2022-E S G O .14。建议的测试是Myriad myChoice HRD测试的可行替代方案,可以很容易地在临床实验室中进行常规实践。就危险比而言,这两种测试的性能相似,但日内瓦HRD测试的失败率较低,从而使获得结结性实验室结果的患者人数增加了10%。Dong Bach Nguyen, Beatriz Navarro Santana, Guillaume Babin, Sara Forte, Mathilde mair, fracimadric Guyon。应用ICG荧光评估直肠吻合和输尿管完整性妇科肿瘤研究所,法国波尔多10.1136/ijgc-2022-ESGO.515自1968年Hudson描述了使用逆行技术整体切除固定卵巢肿瘤以来,卵巢癌子宫切除术的手术入路基本保持不变。当需要结肠切除以达到最佳减积时,吻合口漏仍然是一个值得关注的问题。虽然用于评估吻合口灌注的传统技术缺乏准确性,但最近的系统回顾和荟萃分析的数据支持使用ICG术中以减少吻合口泄漏的发生率和相关的再干预需求。本视频使用手术镜头,旨在介绍结肠直肠癌哈德森手术的手术步骤,最后使用ICG荧光评估结肠吻合口和输尿管的灌注情况。结果手术入路可分为以下10个步骤:(1)腹膜后血管蒂、输尿管夹层及IP韧带横断;(2)切除膀胱旁和直肠旁间隙;(3)外侧及膀胱前腹膜切除术;(4)输尿管溶解和子宫血管横断;(5)腹水韧带和子宫骶韧带横断;(6)阴道切开术;(7)直肠肠系膜清扫和直肠远端横断;(8)近端直肠乙状结肠横断;(9)阴道穹窿闭合及结肠吻合术;(10) ICG荧光评价结直肠吻合及输尿管血管形成。结论本视频展示了10个可重复的步骤来执行哈德逊手术和结直肠癌切除卵巢癌。使用ICG作为评估结直肠吻合处血管化的辅助手段,似乎可以降低结直肠手术中吻合口漏的风险,并且可能对妇科肿瘤手术感兴趣。Laura Naomi Beckmann、Sara Alavi、Maren Keller、Clemens Liebrich、Karol Kubiak、Pauline Wimberger、Vera Czolk、Anette Ligl-Löhner、Hans-Martin Enzinger、Aline burack、Dorothea Fischer、j rgen Terhaag、Cornelia m ller、Volker Hanf、Mateja Condic、Georg Kunz、Tilmann Lantzsch、Ute Schilling、g lten Oskay-Özcelik, Jalid Sehouli报道。德国柏林医科大学Virchow-Klinikum校区慈善基金会欧洲卵巢癌能力中心肿瘤外科中心妇科;德国东北妇科肿瘤学会(NOGGO),柏林,德国;Gynäkologisches德国沃尔夫斯堡Klinikum Wolfsburg Krebszentrum;St. Franziskus-Hospital GmbH,德国m nster;德累斯顿卡尔·古斯塔夫·卡鲁斯医科大学妇产科,德国德累斯顿;Diako Mannheim,曼海姆,德国;Diakonissen-Stiftung-Krankenhaus Speyer,施佩尔,德国;班贝格社,班贝格,德国;Sana Klinikum Lichtenberg,柏林,德国;Klinikum Ernst von Bergmann gemeinn tzige有限公司,德国波茨坦;Rottal-Inn Kliniken KU Eggenfelden,德国Eggenfelden;Universitätklinikum Brandenburg and der Havel, Brandenburg and der Havel,德国;Klinikum f rth, f rth,德国;Universitätsklinikum波恩,德国波恩;多特蒙德圣约翰医院,多特蒙德,德国;Krankenhaus St. Elisabeth und St. Barbara Halle (Saale) GmbH, Halle (Saale),德国;柏林Park-Klinik Weißensee,